Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201009705 Principal Investigator: Waqar, Saiama
Title: A Randomized, Double-Blind Phase 3 Study of Docetaxel and Ramucirumab versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer Following Disease Progression After One Prior Platinum-Based Therapy
Phase: III Disease Site: Lung
Participating Site(s):
 
Main Campus
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to see whether an experimental chemotherapy drug, called ramucirumab, can help lung cancer patients live longer when it is given with another regular chemotherapy treatment (docetaxel).
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)